Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Genistein in Metastatic Breast Cancer
NCT00244933Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Feb 2004
- Primary completion
- Nov 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of genistein in breast cancer, sponsored by Barbara Ann Karmanos Cancer Institute. Started Feb 2004; status: completed.
02
Drugs
genistein
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00244933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244933.